WHERE: Vienna Congress and Convention Center, Vienna, Austria.
TYPE: Attending
At Resyca, we’re redefining how pulmonary and nasal therapies reach patients.
Our next-generation soft mist inhalation technology delivers exceptional efficiency, low residual volumes and proven scalability — all while ensuring patient comfort and sustainable design.
From early-stage biologics to established formulations, our customisable platform enables seamless transition from prototype to market-ready product, with built-in sterile integrity and minimal development risk.
Join us at Bio-Europe to discover how we can accelerate your innovation. Helping you move faster, smarter and more sustainably toward commercial success.
Book a meeting with Resyca at Bio-Europe below.
[HUBSPOT FORM TO BE EMBEDDED]
